Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled trial of MEBO for diabetic foot ulcer
CTR20263111Phase 2Active
- Sponsor
- Shantou MEBO Pharmaceutical
- Start
- Aug 2026
- Countries
- 1
01
Overview
A Phase 2 trial of MEBO in diabetic foot ulcer (DFU), sponsored by Shantou MEBO Pharmaceutical. Started Aug 2026; status: active.
02
Drugs
MEBO
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on CTR20263111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263111.